Early research (Phase 1)Study completedNCT01290172
What this trial is testing
Evaluation of Efficacy and Safety of Somatostatin Used as Inflow Modulator in Liver Transplantation.
Who this might be right for
Liver Transplant With Clinically Significant Portal Hypertension
University Hospital, Ghent 33